Is Retinoblastoma hereditary?

Retinoblastoma is a genetic condition caused by mutations in the RB1 gene, but it is not always hereditary. While approximately 40% of cases are germline (hereditary) and can be passed down to offspring, the remaining 60% of cases are unilateral and result from de novo (spontaneous) somatic mutations that occur after conception and are not passed to children.

Is Retinoblastoma hereditary or sporadic?

Understanding whether Retinoblastoma is hereditary depends on the type of mutation present. In roughly 60% of patients, the mutation is "sporadic" or somatic, meaning the genetic change is confined only to the tumor cells in the eye and is not present in the rest of the body’s cells. In these cases, the disease is not hereditary, and the risk of the patient passing Retinoblastoma to their children is not increased compared to the general population. Conversely, in about 40% of cases, the mutation is "germline," meaning it is present in every cell of the body. These individuals have a hereditary form of Retinoblastoma and can pass the mutation to their offspring.

What is the inheritance pattern of hereditary Retinoblastoma?

When Retinoblastoma is hereditary, it follows an autosomal dominant inheritance pattern. This means that a person with a germline RB1 gene mutation has a 50% chance of passing that mutation to each of their children. However, it is important to note that inheriting the mutation does not guarantee the development of the disease; the condition exhibits high, but not 100%, penetrance. Furthermore, de novo mutations—new genetic changes that arise spontaneously in the egg or sperm—are very common, often occurring in families with no prior history of the disease.

How is genetic testing used for families?

Genetic testing for Retinoblastoma is a critical component of clinical management. It is recommended for all children diagnosed with the disease to determine if the mutation is somatic or germline. If a germline mutation is identified, testing is then offered to parents and siblings to determine who else may be at risk. Clinical geneticists use the following approaches to manage risk:

• Mutation Analysis: Sequencing the RB1 gene to identify the specific pathogenic variant.


• Predictive Testing: Testing asymptomatic siblings of a child with germline Retinoblastoma to determine if they require frequent eye screenings.


• Prenatal and Preimplantation Genetic Diagnosis (PGD): Options available for families with a known germline mutation who wish to assess pregnancy risks or select embryos without the RB1 mutation.

What is the role of genetic counseling?

Genetic counseling is essential for families navigating a Retinoblastoma diagnosis. A counselor provides clarity on the complex distinction between somatic and germline mutations, helps interpret test results, and discusses reproductive options. For survivors of hereditary Retinoblastoma who are planning a family, counseling provides an evidence-based assessment of recurrence risks and outlines the surveillance strategies necessary for future children who may inherit the susceptibility.

Next steps

• Consult with a board-certified clinical geneticist to discuss whether your child's Retinoblastoma is somatic or germline.


• Request a referral to a pediatric ophthalmologist specializing in ocular oncology for long-term surveillance.


• Connect with the DiseaseMaps.org community to share experiences and find support from others navigating the same genetic journey.


• Review resources from the American Association of Ophthalmic Oncologists and Pathologists for the latest clinical guidelines.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Retinoblastoma.


• Orphanet: Retinoblastoma (ORPHA:790).


• OMIM (Online Mendelian Inheritance in Man): Retinoblastoma (RB1 gene).


• American Association for Pediatric Ophthalmology & Strabismus (AAPOS): Retinoblastoma Information.